The Journal of Lipid Research, a peer-reviewed journal published by the American Society for Biochemistry and Molecular Biology, has appointed six junior faculty members to its editorial leadership team. One of the appointments is Scott M. Gordon, assistant professor in the Department of Physiology at the University of Kentucky College of Medicine, where his lab studies intestinal lipid absorption and atherosclerotic cardiovascular disease.
News
MAYSVILLE, Ky. (May 20, 2021) – On May 19, Meadowview Regional Medical Center (MRMC), part of LifePoint Health, hosted a ribbon cutting ceremony to mark the expansion of its cancer treatment facilities in Maysville, Ky. and announced its formal collaboration with the University of Kentucky (UK) Markey Cancer Center as part of the UK Markey Cancer Center Affiliate Network (MCCAN). A small group of leaders from the hospital, LifePoint and MCCAN gathered to celebrate the reopening of the facility and launch of the collaboration.
LEXINGTON, Ky. (May 19, 2021) — The past year has been filled with new routines, new rules, and new fears for many people as the world has navigated the ongoing COVID-19 pandemic. During this time staff members at UK HealthCare’s Barnstable Brown Diabetes Center (BBDC) found a unique way to ease some anxiety as young patients and their families returned to in-person clinic visits.
LEXINGTON, Ky. (May 19, 2021) – Jardin Dogan says her clinical practice and own life experiences have inspired her research, which is helping to eliminate mental, social and sexual health disparities for Black people.
The counseling psychology doctoral candidate in the University of Kentucky’s College of Education counsels people who are experiencing mental health issues from racial trauma, substance abuse and criminal justice involvement.
LEXINGTON, Ky. (May 18, 2021) – Though she grew up in California, University of Kentucky Markey Cancer Center research assistant Sumati Hasani spent many summers of her childhood visiting her extended family in India. The first-generation South Asian American has many fond memories of visiting her family overseas, whose residences spanned every corner of the country.
In Kentucky, more than 36 percent of the adult population is obese, and nearly 14 percent have been diagnosed with diabetes. Due to the complexity of both diabetes and obesity, these issues are difficult to address – and impossible to solve – when focused through only one lens.
LEXINGTON, Ky. (May 6, 2021) — A University of Kentucky College of Medicine professor has been awarded a $1.9 million National Institutes of Health (NIH) grant for his research on the body’s immune response to sepsis, which could potentially help to improve therapies for the common disease.
LEXINGTON, Ky. (May 5, 2021) — Collaborative research between the University of Kentucky and the University of Southern California (USC) suggests that a noninvasive neuroimaging technique may index early-stage blood-brain barrier (BBB) dysfunction associated with small vessel disease (SVD). Cerebral SVD is the most common cause of vascular cognitive impairment, with a significant proportion of cases going on to develop dementia.
For many years, ventricular assist devices (VADs) were considered a last resort for patients with serious heart failure. These mechanical pumps, which help maintain blood circulation, were mainly used for patients awaiting a heart transplant.
Recent studies conducted by University of Kentucky researchers suggest VADs actually could be used to recover the hearts of patients with heart failure, even those with advanced heart failure, possibly preventing their need for transplants in the future.
LEXINGTON, Ky. (April 29, 2021) —The 13th annual University of Kentucky Sanders-Brown Center on Aging Mind Matters Health Fair is set to take place from 10 a.m. to noon, Monday, May 3. The format will follow last year’s move to a virtual platform to ensure the continued health and safety of both the presenters and attendees.
LEXINGTON, Ky. (April 27, 2021) – A recent study by University of Kentucky Markey Cancer Center researchers looked into the association of financial burden with health insurance literacy in colorectal cancer patients.
LEXINGTON, Ky. (April 26, 2021) — From Kentucky farms to University of Kentucky labs and now to Kentucky patients, the UK Markey Cancer Center has officially launched a unique new clinical trial to test whether Artemisia annua extract can prevent ovarian cancer recurrence.
LEXINGTON, Ky. (April 23, 2021) – We are inching ever closer to a return to normal with each scheduled COVID-19 vaccine appointment at the University of Kentucky Kroger Field clinic.
As each person walks through the line of tents at Kroger Field, checks in and winds their way up to their vaccination station, you can’t help but wonder, what’s their reason? Why are they choosing to be vaccinated?
Dr. Vincent L. Sorrell, the Anthony N. DeMaria professor of Medicine and the director of Advanced Cardiovascular Imaging at UK Gill Heart & Vascular Institute, will become editor-in-chief of CASE, an international cardiovascular imaging case reports journal.
LEXINGTON, Ky. (April 20, 2021) – A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
The NIH Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases, in collaboration with the Center for Clinical and Translational Sciences (CCTS) announce the availability of limited funds to support pilot projects focused on research examining obesity-associated diseases.
LEXINGTON, Ky. (April 19, 2021) — One out of three individuals in the U.S. complain of sleep disturbances in their lifetime and 10% of the general population meet the diagnostic criteria of chronic sleep disorders. That number has risen among elderly individuals to 48% and over 50% among pregnant women.
In order to maximize the impact of novel research, every research team needs a plan to bring those findings to the clinic and the communities who need health care treatments. A group of clinicians and scientists at the University of Kentucky is working to launch research discoveries beyond the walls of an academic medical center and into broader contexts – clinical practice, population health, and policy development – in order to efficiently promote research into the real world, particularly in underserved areas.
Successful research practices find solutions that translate from the bench to the bedside, and while that’s important, Vivek Rangnekar, PhD, underscores that it’s even more effective as a bidirectional and cyclical rather than a linear process.
“Generally, we talk about bench-to-bedside translation of ideas or research projects,” Dr. Rangnekar said. “On the other hand, with cancer, clinical observations – for example, how the patient is responding to treatment – is very important, and those insights are gained primarily in the clinic.”
A number of University of Kentucky experts will be giving presentations on their work in the field of opioid use disorder research, treatment and prevention this week at the 2021 Rx Drug Abuse and Heroin Summit, held virtually this year due to the ongoing pandemic.